4 reports

  • diagnosed with Cancer.
  • BYPRODUCTS

Liquid biopsy is process of obtaining non-solid tissue usually the blood and other body fluids (urine, saliva etc. ) obtained non-invasively as a diagnosis and monitoring tool for disease such as cancer through identification of biomarker in form of cell-fee DNA or circulating tumor cells (CTC) to advance personalized...

  • Biopsy
  • Cancer
  • Diagnostics
  • Healthcare
  • Natera, Inc.
  • 4.3.1 INTORDUCTION
  • 8.10.4 KEY DEVELOPMENTS

NEARLY ##% OF PATIENTS WITH STAGE ## CANCERS CAN BE DETECTED THROUGH CTDNA AND DETECTION RATE GOES UP TO ##% WITH PATIENTS HAVING LATE STAGE OR STAGE ## CANCERS.

  • Cancer
  • DNA
  • Biocept, Inc.
  • CareDx, Inc.
  • Natera, Inc.

The average blood plasma concentration of DNAase I is ##. ## - ##. ##ng mL-## whilst the average serum RNAase value is ## units mL -##.

  • Cancer
  • Genomics
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.